BJG-05-039

N/A

Report date: 2022/11/24 15:37:50
NME

Base Information

Drug NameBJG-05-039
Drug Alias NameBJG-05-039
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase PAK 1 degraders
TargetsSerine/threonine-protein kinase PAK 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFox Chase Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesFox Chase Cancer Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A